Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer Of 1,066 patients with a DTC result at BM2 and ...
Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer Patients with early breast cancer who had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results